secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001493152-24-020007
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics files PCT patent for ImmunePrep platform to enhance antibody delivery for cancer treatment
--------------------------------------------------------------------------------

- Filed PCT application US24/28579 on May 9, 2024 for 'DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES'.
- Patent covers ImmunePrep platform aimed at improving delivery of immunotherapeutic antibodies for cancer.
- Inventors listed: Chairman and CEO James A. Joyce and Annette M. Marleau.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224020007/0001493152-24-020007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224020007/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer